- Home
- CALC vs HKIT Comparison
CALC vs HKIT Comparison
Compare CALC & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- HKIT
- Stock Information
- Founded
- CALC 2011
- HKIT 1996
- Country
- CALC United States
- HKIT China
- Employees
- CALC N/A
- HKIT N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- HKIT Computer Software: Prepackaged Software
- Sector
- CALC Health Care
- HKIT Technology
- Exchange
- CALC Nasdaq
- HKIT Nasdaq
- Market Cap
- CALC 48.1M
- HKIT 39.8M
- IPO Year
- CALC N/A
- HKIT 2023
- Fundamental
- Price
- CALC $3.09
- HKIT $1.54
- Analyst Decision
- CALC Strong Buy
- HKIT
- Analyst Count
- CALC 2
- HKIT 0
- Target Price
- CALC $14.50
- HKIT N/A
- AVG Volume (30 Days)
- CALC 53.0K
- HKIT 10.3K
- Earning Date
- CALC 08-12-2025
- HKIT 10-27-2025
- Dividend Yield
- CALC N/A
- HKIT N/A
- EPS Growth
- CALC N/A
- HKIT N/A
- EPS
- CALC N/A
- HKIT N/A
- Revenue
- CALC N/A
- HKIT $2,904,950.00
- Revenue This Year
- CALC N/A
- HKIT N/A
- Revenue Next Year
- CALC N/A
- HKIT N/A
- P/E Ratio
- CALC N/A
- HKIT N/A
- Revenue Growth
- CALC N/A
- HKIT N/A
- 52 Week Low
- CALC $1.42
- HKIT $1.15
- 52 Week High
- CALC $5.97
- HKIT $1.79
- Technical
- Relative Strength Index (RSI)
- CALC 56.35
- HKIT 58.76
- Support Level
- CALC $3.04
- HKIT $1.48
- Resistance Level
- CALC $3.38
- HKIT $1.54
- Average True Range (ATR)
- CALC 0.24
- HKIT 0.03
- MACD
- CALC 0.02
- HKIT -0.00
- Stochastic Oscillator
- CALC 58.57
- HKIT 69.31
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.